For the quarter ending 2026-03-31, AMPY has $581,106K in assets. $160,539K in debts. $41,486K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 41,486 | 60,666 | 0 | 0 |
| Accounts receivable, net (see note 13) | 19,860 | 30,141 | 33,207 | 34,692 |
| Short-term derivative instruments | 0 | 15,429 | 10,983 | 9,909 |
| Prepaid expenses and other current assets | 23,926 | 24,358 | 26,168 | 25,412 |
| Total current assets | 85,272 | 130,594 | 70,358 | 70,013 |
| Oil and natural gas properties, successful efforts method | 409,197 | 388,920 | 903,217 | 886,441 |
| Assets held for sale - non-current assets | - | - | - | 24,333 |
| Support equipment and facilities | 155,576 | 154,954 | 154,844 | 153,825 |
| Other | 9,637 | 9,601 | 12,404 | 12,126 |
| Accumulated depreciation, depletion and amortization | 370,194 | 364,534 | 711,469 | 668,463 |
| Property and equipment, net | 204,216 | 188,941 | 358,996 | 383,929 |
| Long-term derivative instruments | 0 | 3,425 | 273 | 0 |
| Restricted investments | 42,747 | 40,241 | 37,684 | 35,093 |
| Operating lease - long term right-of-use asset | 2,698 | 2,998 | 3,730 | 4,136 |
| Deferred tax asset | 244,892 | 233,334 | 258,600 | 251,718 |
| Other long-term assets | 1,281 | 1,367 | 1,714 | 2,085 |
| Total assets | 581,106 | 600,900 | 731,355 | 771,307 |
| Accounts payable | 22,477 | 17,901 | 29,154 | 30,303 |
| Revenues payable | 7,505 | 5,638 | 10,145 | 11,736 |
| Accrued liabilities (see note 13) | 20,684 | 34,518 | 29,698 | 41,215 |
| Short-term derivative instruments | 22,776 | - | - | - |
| Total current liabilities | 73,442 | 58,057 | 68,997 | 83,254 |
| Long-term debt (see note 8) | - | - | 123,000 | 130,000 |
| Assets held for sale - non-current liabilities | - | - | - | 1,333 |
| Asset retirement obligations | 73,504 | 72,376 | 133,276 | 131,464 |
| Long-term derivative instruments | 1,818 | - | - | 730 |
| Operating lease liability | 2,341 | 2,568 | 2,985 | 3,268 |
| Other long-term liabilities | 9,434 | 9,176 | 10,123 | 9,953 |
| Total liabilities | 160,539 | 142,177 | 338,381 | 360,002 |
| Common stock, 0.01 par value 250,000,000 shares authorized 41,288,706 and 40,719,957 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 413 | 407 | 405 | 404 |
| Additional paid-in capital | 445,770 | 445,816 | 444,480 | 441,846 |
| Accumulated earnings (deficit) | -25,616 | 12,500 | -51,911 | -30,945 |
| Total stockholders' equity | 420,567 | 458,723 | 392,974 | 411,305 |
| Total liabilities and equity | 581,106 | 600,900 | 731,355 | 771,307 |